Zhao Doctor Chief Physician

Peking University Cancer Hospital · Chief Physician

Position: Deputy Director Professional Title: Chief Physician Specialties: Diagnosis and treatment of various thoracic tumors (including lung cancer, thymic tumors, pleural mesothelioma, etc.)

Diagnosis and treatment of various thoracic tumors (including: lung cancer, thymic tumors, pleural mesothelioma, etc.).

Zhao Doctor
Basic Information

About Dr. Zhao Doctor

Hospital
Peking University Cancer Hospital
Title
Chief Physician
Department
Years of Practice
28 years (1998 — present)
Position: Deputy Director
 
Professional Title: Chief Physician
 
Specialties: Diagnosis and treatment of various thoracic tumors (including lung cancer, thymic tumors, pleural mesothelioma, etc.)
 
Representative Achievements:
 
Research Project: Study on the Function and Mechanism of HDGF‑mediated CAFs in Promoting the Maintenance of NSCLC Cancer Stem Cells in Chemotherapy Resistance. General Program of National Natural Science Foundation of China
Publications:
  1. Prevalence, genetic variations and clinical outcomes of BRAF‑V600 mutated advanced NSCLC in China: a retrospective real‑world multi‑centre study. EBioMedicine 2025 Apr:114:105652. doi: 10.1016. Corresponding Author
  2. Efficacy and safety of first‑line chemoimmunotherapy in young patients with extensive‑stage small cell lung cancer: a multicenter retrospective study. BMC Cancer volume 25, Article number: 1136 (2025). Co‑corresponding Author
  3. High‑dose hyperfractionated simultaneous integrated boost radiotherapy versus standard‑dose radiotherapy for limited‑stage small‑cell lung cancer in China: a multicentre, open‑label, randomised, phase 3 trial. Lancet Respir Med. 2024 Oct;12(10):799‑809. Corresponding Author
  4. Anlotinib hydrochloride consolidation after concurrent chemoradiotherapy in stage III non‑small‑cell lung cancer: a truncated, randomized, multicenter, clinical study (ALTER‑L029) Anticancer Drugs. 2024 Aug 1;35(7):680‑685. Corresponding Author
  5. First‑line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive‑stage small‑cell lung cancer. BMC Cancer. 2023; 23: 318. Corresponding Author
Science and Technology Awards:
 
First Prize for Science and Technology Progress of the Ministry of Education (2019): Establishment and Clinical Promotion of Lung Cancer Individualized Diagnosis and Treatment System Based on Peripheral Blood Molecular Subtyping (Fourth Completion Author)
Schedule

Dr. Zhao Doctor — Outpatient Schedule

Weekly clinic, including specialist and surgery days. Book 3-7 days in advance.

Clinic: Peking University Cancer Hospital · Department
On Duty
Off Duty
Period Morning
08:00-12:00
Afternoon
14:00-17:30
Evening
18:30-20:30
Mon Off Duty Off Duty Off Duty
Tue Off Duty
13:30 - 17:00
Off Duty
Wed Off Duty Off Duty Off Duty
Thu Off Duty
13:30 - 17:00
Off Duty
Fri Off Duty Off Duty Off Duty
Sat Off Duty Off Duty Off Duty
Sun Off Duty Off Duty Off Duty
Note: Actual clinic hours are subject to the hospital's daily notice. Please call the Dovecure 24h hotline 400-888-0000 to confirm before booking.

Rationale for Precision

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Book your dedicated advisor now

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Consult Now
24/7 medical consultation +86 18126771334 (iMessage)
Email Consultation cure@dovecure.com
WhatsApp WeChat QR Code WeChat QR Code
Cart
Your cart is empty
Continue shopping
{{ item.sku_code }} - {{ item.variant_label }} {{ item.item_type_label }}
{{ item.price_format }}
{{ item.subtotal_format }}
Total {{ totalAmount }}
Checkout View Cart
Consult